immatics biotechnologies GmbH (4A3) — Cash Flow Reinvestment Rate
immatics biotechnologies GmbH (4A3) has a Cash Flow Reinvestment Rate of 0.87x as of December 2023, reinvesting €69.03 Million (capex €9.29 Million plus investments €59.74 Million) from operating cash flow of €79.08 Million. See 4A3 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
immatics biotechnologies GmbH Cash Flow Reinvestment Rate (2018–2023)
Historical reinvestment intensity for immatics biotechnologies GmbH across 6 annual periods. For the full cash flow conversion analysis, see 4A3 operating cash flow.
Annual Cash Flow Reinvestment Rate for immatics biotechnologies GmbH (2018–2023)
Year-by-year capital reinvestment analysis for immatics biotechnologies GmbH. See how financially flexible is immatics biotechnologies GmbH to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 3.42x | €62.34 Million | €18.23 Million | €30.96 Million | ▲ +63.6% |
| 2022 | 2.09x | €209.37 Million | €100.13 Million | €5.74 Million | ▲ +1046.8% |
| 2021 | 0.18x | €18.26 Million | €100.13 Million | €5.11 Million | ▲ +15.2% |
| 2020 | 0.16x | €15.85 Million | €100.13 Million | €7.42 Million | ▲ +121.7% |
| 2019 | 0.07x | €5.07 Million | €70.97 Million | €2.14 Million | ▼ -89.1% |
| 2018 | 0.65x | €13.53 Million | €20.68 Million | €429.00K | — |